| RS1453504440 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS145350474 |
ABCC2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS145350631 |
PEX1
|
Health Risk |
Conflicting classifications of pathogenicity |
Zellweger spectrum disorders, Inborn genetic diseases |
| RS1453508139 |
COL12A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ullrich congenital muscular dystrophy 2, Bethlem myopathy 2 |
| RS145350949 |
SLC22A5
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal carnitine transport defect, Inborn genetic diseases |
| RS1453510719 |
SPR
|
Health Risk |
Conflicting classifications of pathogenicity |
Dopa-responsive dystonia due to sepiapterin reductase deficiency, Dystonic disorder |
| RS145351367 |
SBF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4B2 |
| RS145351589 |
AP3B1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hermansky-Pudlak syndrome 2, Inborn genetic diseases |
| RS145351963 |
RBFOX1
|
Health Risk |
Conflicting classifications of pathogenicity |
Idiopathic generalized epilepsy, Inborn genetic diseases |
| RS145352110 |
CNTN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Epilepsy, familial adult myoclonic |
| RS145352569 |
COL6A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Myosclerosis |
| RS145352934 |
CEP250
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1453532929 |
AMMECR1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1453533016 |
HADHA
|
Health Risk |
Conflicting classifications of pathogenicity |
Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency, Mitochondrial trifunctional protein deficiency |
| RS145353444 |
FBN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital contractural arachnodactyly, Ehlers-Danlos syndrome |
| RS145353541 |
CDHR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cone-rod dystrophy 15, Retinal dystrophy |
| RS145354256 |
RASA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Capillary malformation-arteriovenous malformation 1, Cardiovascular phenotype |
| RS145355104 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS145355907 |
COL1A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Connective tissue disorder, Predisposition to dissection |
| RS145356388 |
MMP19
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS145356495 |
PREPL
|
Health Risk |
Pathogenic/Likely pathogenic |
Myasthenic syndrome, congenital |
| RS145356792 |
MSN
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1453568434 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS145357582 |
PTPRC
|
Health Risk |
Conflicting classifications of pathogenicity |
Immunodeficiency 104, Immunodeficiency 104 |
| RS1453585230 |
RAI1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1453590085 |
COL4A3
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive Alport syndrome, Autosomal dominant Alport syndrome |
| RS145360241 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS145360423 |
NCF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Granulomatous disease, chronic |
| RS145360792 |
HNF4A
|
Health Risk |
Conflicting classifications of pathogenicity |
Type 2 diabetes mellitus, Maturity-onset diabetes of the young type 1 |
| RS145361083 |
PGAP6
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS145361258 |
SIM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Obesity due to SIM1 deficiency, SIM1-related disorder |
| RS145361574 |
SATB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental delay with dysmorphic facies and dental anomalies, Developmental delay with dysmorphic facies and dental anomalies |
| RS145361939 |
BAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
BAP1-related tumor predisposition syndrome, Hereditary cancer-predisposing syndrome |
| RS145362059 |
DSP
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Arrhythmogenic right ventricular dysplasia 8 |
| RS145362161 |
AGL
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS145362529 |
LRP5
|
Health Risk |
Conflicting classifications of pathogenicity |
LRP5-related disorder, LRP5-related disorder |
| RS145362908 |
NPC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Niemann-Pick disease, type C1 |
| RS1453641005 |
POMT1
|
Health Risk |
Likely pathogenic |
— |
| RS1453646167 |
PKHD1
|
Health Risk |
Likely pathogenic |
Autosomal recessive polycystic kidney disease, Polycystic kidney disease 4 |
| RS145365423 |
LZTS1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS145365677 |
TCOF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Treacher Collins syndrome 1, Treacher Collins syndrome 1 |
| RS145365776 |
LRP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Donnai-Barrow syndrome, Donnai-Barrow syndrome |
| RS145366078 |
DYNC1H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2O, Intellectual disability |
| RS145366738 |
CHIT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Chitotriosidase deficiency, Chitotriosidase deficiency |
| RS145367055 |
TG
|
Health Risk |
Conflicting classifications of pathogenicity |
Iodotyrosyl coupling defect, Iodotyrosyl coupling defect |
| RS145367849 |
MANBA
|
Health Risk |
Conflicting classifications of pathogenicity |
Beta-D-mannosidosis, Sarcoma |
| RS145368798 |
UPB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Deficiency of beta-ureidopropionase, Deficiency of beta-ureidopropionase |
| RS145369252 |
CABP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 93, Nonsyndromic genetic hearing loss |
| RS1453695821 |
MSH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS145369754 |
SLC37A4
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease, type I |
| RS1453700499 |
MAK
|
Health Risk |
Likely pathogenic |
— |
| RS145370736 |
SERPIND1
|
Health Risk |
Conflicting classifications of pathogenicity |
SERPIND1-related disorder, SERPIND1-related disorder |
| RS1453708640 |
ASS1
|
Health Risk |
Pathogenic |
Citrullinemia, Citrullinemia |
| RS145371235 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Charlevoix-Saguenay spastic ataxia, Spastic paraplegia |
| RS145371658 |
APP
|
Health Risk |
Conflicting classifications of pathogenicity |
Alzheimer disease, Inborn genetic diseases |
| RS1453717899 |
SI
|
Health Risk |
Conflicting classifications of pathogenicity |
Sucrase-isomaltase deficiency, Sucrase-isomaltase deficiency |
| RS1453718975 |
MYO7A
|
Health Risk |
Pathogenic |
Usher syndrome type 1B, Usher syndrome type 1B |
| RS145372075 |
AHI1
|
Health Risk |
Conflicting classifications of pathogenicity |
AHI1-related disorder, AHI1-related disorder |
| RS145372387 |
HPDL
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities, Spastic paraplegia |
| RS145372405 |
POU4F3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nonsyndromic hearing loss 15, POU4F3-related disorder |
| RS145373075 |
CTSC
|
Health Risk |
Conflicting classifications of pathogenicity |
Haim-Munk syndrome, Papillon-Lefèvre syndrome |
| RS145373149 |
DCHS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS145373396 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS145373839 |
ABCG8
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, ABCG8-related disorder |
| RS145373891 |
VIPAS39
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1453752069 |
SDHA
|
Health Risk |
Pathogenic |
Mitochondrial complex II deficiency, nuclear type 1 |
| RS145375625 |
DNAH3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1453761645 |
NAGLU
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-B |
| RS1453766111 |
SETD5
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS145377049 |
JAK3
|
Health Risk |
Conflicting classifications of pathogenicity |
T-B+ severe combined immunodeficiency due to JAK3 deficiency, T-B+ severe combined immunodeficiency due to JAK3 deficiency |
| RS1453773610 |
POMT1
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2K, Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability) |
| RS1453780248 |
ACVRL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Telangiectasia, hereditary hemorrhagic |
| RS145378038 |
SLC4A4
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive proximal renal tubular acidosis, SLC4A4-related disorder |
| RS145378071 |
IL17RA
|
Health Risk |
Conflicting classifications of pathogenicity |
Immunodeficiency 51, See cases |
| RS1453785436 |
ADAMTS2
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, dermatosparaxis type |
| RS1453792999 |
MLH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1453794304 |
COL7A1
|
Health Risk |
Likely pathogenic |
— |
| RS145379710 |
SLC45A2
|
Health Risk |
Pathogenic/Likely pathogenic |
SLC45A2-related disorder, Oculocutaneous albinism type 4 |
| RS145380453 |
FOLR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cerebral folate transport deficiency, Inborn genetic diseases |
| RS145381088 |
COL7A1
|
Health Risk |
Conflicting classifications of pathogenicity |
COL7A1-related disorder, Inborn genetic diseases |
| RS145381639 |
COL6A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS1453829048 |
MPDZ
|
Health Risk |
Pathogenic |
— |
| RS145383120 |
ABCA3
|
Health Risk |
Conflicting classifications of pathogenicity |
Interstitial lung disease due to ABCA3 deficiency, Hereditary pulmonary alveolar proteinosis |
| RS1453839157 |
ATR
|
Health Risk |
Conflicting classifications of pathogenicity |
Seckel syndrome 1, Inborn genetic diseases |
| RS145383974 |
CUBN
|
Health Risk |
Conflicting classifications of pathogenicity |
Imerslund-Grasbeck syndrome type 1, Imerslund-Grasbeck syndrome |
| RS1453842331 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal cell carcinoma, Hereditary cancer-predisposing syndrome |
| RS145384260 |
NF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 2 |
| RS1453857349 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 2 |
| RS1453858339 |
FBN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital contractural arachnodactyly, Familial thoracic aortic aneurysm and aortic dissection |
| RS1453864069 |
EXOSC9
|
Health Risk |
Pathogenic |
— |
| RS145386421 |
ABCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary hyperinsulinism, Maturity-onset diabetes of the young |
| RS1453865021 |
COG6
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, COG6-related disorder |
| RS145386883 |
MCOLN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucolipidosis type IV, Inborn genetic diseases |
| RS145387010 |
ANKRD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, ANKRD1-related dilated cardiomyopathy |
| RS145387062 |
SLC6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Epilepsy with myoclonic atonic seizures, Epilepsy with myoclonic atonic seizures |
| RS145387081 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group O, Hereditary cancer-predisposing syndrome |
| RS1453871309 |
SLC3A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Cystinuria, Cystinuria |
| RS145387221 |
FKTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Walker-Warburg congenital muscular dystrophy, Cardiovascular phenotype |
| RS145387373 |
LAMC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS145387575 |
PKP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular dysplasia 9, Cardiomyopathy |